Key result
Ghrelin and MSC-derived exosomes attenuate histological and immunohistochemical damage in experimental chronic pancreatitis.
Why the study?
Chronic pancreatitis is characterized by irreversible pancreatic damage and the potential therapeutic effects of ghrelin and MSC-derived exosomes require evaluation.
Does treatment with ghrelin and/or MSC-derived exosomes improve histological and immunohistochemical markers in a rat model of induced chronic pancreatitis?
RCT (n=62)
randomly divided
Does treatment with ghrelin and/or MSC-derived exosomes improve histological and immunohistochemical markers in a rat model of induced chronic pancreatitis?
Ghrelin and MSC-derived exosomes demonstrate potential therapeutic effects in ameliorating histological damage in a rat model of chronic pancreatitis.
May benefit experimental CP in rats; leaves open any human therapeutic role pending clinical studies.
No takes yet. Share an insight, caveat, or question.
Samy et al. (2022) conducted an RCT in chronic pancreatitis (n=62). ghrelin and MSCs derived exosomes vs. control group and affected group was evaluated on histological and immunohistochemical changes. Ghrelin and MSC-derived exosomes improved histological microscopic changes in adult albino rats with induced chronic pancreatitis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: